The initial success of Viagra undeniably transformed the drug landscape, but betting in companies heavily reliant on generic versions presents a complex picture. Although early earnings were impressive, the end of patents and the rise of less expensive alternatives have diminished sales. Thus, a thorough analysis of ongoing financial performance an